Kurdish Progressive Party to Asharq Al-Awsat: Damascus’ Opting for Military Solution Led to Foreign Meddling

Kurdish Democratic Progressive Party politburo official Ahmed Sulaiman. (Asharq Al-Awsat)
Kurdish Democratic Progressive Party politburo official Ahmed Sulaiman. (Asharq Al-Awsat)
TT

Kurdish Progressive Party to Asharq Al-Awsat: Damascus’ Opting for Military Solution Led to Foreign Meddling

Kurdish Democratic Progressive Party politburo official Ahmed Sulaiman. (Asharq Al-Awsat)
Kurdish Democratic Progressive Party politburo official Ahmed Sulaiman. (Asharq Al-Awsat)

The Kurdish Democratic Progressive Party, one of Syria’s oldest Kurdish parties, believes that efforts to normalize relations between the Damascus regime and Ankara came at Russia’s request and Iranian encouragement in wake of the summit held between Russia, Türkiye and Iran in July.

Kurdish Democratic Progressive Party politburo official Ahmed Sulaiman said they have called for dialogue with Bashar al-Assad's regime to “resolve the Kurdish issue for which we have strived for.”

However, the regime’s resorting to the military option “has complicated the scene.”

In an interview to Asharq Al-Awsat, Sulaiman acknowledged the need to “reassure” Türkiye that the situation in Syria is not a threat to its national security.

The Kurdish Democratic Progressive Party was formed in 1957. It has been striving politically for years to resolve the Kurdish issue as part of a comprehensive political solution in Syria. This lies in the transition to a pluralist democratic system that recognizes Kurds in the country and grants them their legitimate rights. Party officials have over the past 11 years of war held direct talks with regime officials to help reach their goals.

“Perhaps any breakthrough in relations between Ankara and Damascus will favor the Syrian regime above all else,” Sulaiman told Asharq Al-Awsat from Qamishli.

“We support having normal relations between Syria and neighboring countries, including Türkiye,” he added.

Contrary to what Turkish officials claim, the situation in Syria does not pose a threat to their national security, he went on to say.

At the same time, resolving the situation in Syria must not take place at the expense of the Syrian people, especially the Kurds, he stressed.

“We all know that Türkiye’s first and last demand is preventing the resolution of the Kurdish issue in Syria. Should Ankara reach understandings with Damascus, it will insist that the Kurds lose all their administrative and military gains and limit the power of the Syrian Democratic Forces (SDF),” said Sulaiman.

After the battles in Ain al-Arab in 2014, the occupation of Afrin in 2018 and Ras al-Ain and Tall Abyad in 2019, and the migration of thousands of Kurds to neighboring countries and Europe, Kurdish forces should have preserved their independent political decision-making to protect their cause, he remarked.

They should have kept a distance from regional and international meddling in Syria, he added.

Kurdish parties may have made tactical gains, but they squandered potential opportunities to resolve the Kurdish issue, he lamented. The issue is now at the mercy of regional and international interference in Syria.

“Therefore, any solution these international parties may reach over Syria will take place at the expense of the Kurdish people and their rights in the country because they are viewed as the weakest link and least influential on these parties,” he explained.

The Kurdish Democratic Progressive Party had since the eruption of the war been calling for direct negotiations and dialogue with the regime.

Sulaiman said: “We have called for dialogue with the regime to discuss possible solutions, especially regarding the Kurdish issue.”

“The regime, however, opted for the military solution and complicated the possibility of reaching a national solution,” he added.

“Even worse, it opened its arms wide for foreign meddling,” Sulaiman remarked.

Asked if the Progressive Party had held direct meetings with regime and government officials, he replied that such talks were held in Damascus.

The last of these meetings was held in April, revealed Sulaiman.

“We believe that dialogue with the regime demands united Kurdish ranks and a common position over the rights of the Kurdish people,” he went on to say.

“This is why our party visited Damascus. The talks focused on the mechanisms needed to open serious channels of dialogue and understand the regime’s position clearer and its vision of addressing the crisis and resolving the Kurdish issue in specific,” he stated.

“Resolving the Kurdish issue lies in Damascus. Without reaching this conviction, there can be no real solution to the issue in Syria,” he declared.

“We welcome the role played by the United Nations and international mediations, especially Russia’s influence through its close ties with the regime,” he said.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.